Cohero Health
Cohero Health is a New York-based private digital health company, founded in 2013, that develops connected smart inhaler sensors and a respiratory health platform for medication adherence and remote monitoring of asthma and COPD patients.
- Company typePrivate
- Founded2013
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Cohero Health does
Cohero Health is a New York-based private digital health company founded in 2013 that develops a connected health platform for patients with respiratory illness, primarily asthma and chronic obstructive pulmonary disease (COPD). The company's core product is a set of smart inhaler tracking sensors—branded as HeroTracker—that attach to metered dose and Diskus inhalers and capture medication usage, timing, and frequency, transmitting this data via Bluetooth to a software application used for medication adherence monitoring and remote patient management.
Underlying the hardware is a digital respiratory platform aggregating inhaler-usage data with patient-reported outcomes to support disease management for asthma and COPD populations. The company's value proposition centers on improving medication adherence, enabling remote monitoring of respiratory conditions, and providing data on inhaler usage patterns that is otherwise difficult to capture in clinical or home settings. Distribution and revenue mechanics are not publicly disclosed: pricing is not published, named enterprise customers are not disclosed, and the company operates with a headcount of 11–50 employees. Capital has been raised through a Series A led by Zaffre Investments (2015) and a Series B led by Three Leaf Ventures (2016), with strategic participation from Omron Healthcare, Samsung NEXT, BioAdvance, and several other funds, totaling approximately $16.8 million in disclosed equity funding across six rounds through 2017. Leadership is consolidated under CEO and Executive Chairman Joseph Condurso. Notably, the HeroTracker sensor brand currently appears within Aptar Digital Health's connected drug delivery product portfolio, indicating the technology has been incorporated into a global pharma packaging platform's offerings.
Cohero Health firmographics
Firmographics- Name
- Cohero Health
- Legal name
- COHERO Health Inc.
- Website
- https://coherohealth.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cohero Health is a New York-based private digital health company, founded in 2013, that develops connected smart inhaler sensors and a respiratory health platform for medication adherence and remote monitoring of asthma and COPD patients.
- Ownership category
- akta.pro rank
Cohero Health industry classification
Industry- Product category
- Digital Respiratory Health
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM)
- akta.pro secondary industries
- Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE), Asthma & Allergy-Related Pulmonary Care (HLAKANAD)
Keywords
Where Cohero Health is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Cohero Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Cohero Health product offering
Product offeringCore offering
Cohero Health builds a connected respiratory health platform centered on proprietary Bluetooth-enabled smart inhaler sensors (HeroTracker) and a Bluetooth-enabled lung function sensor (MSpirometer) that capture medication usage, timing, frequency, and spirometry data for asthma and COPD patients. The hardware feeds a respiratory disease management software platform that aggregates adherence, lung function, symptom, and trigger data into a single mobile app for patients and their care teams. The platform also includes the Allergy Buddy companion app for allergic rhinitis and seasonal allergy self-management.
Differentiator
Problem solved
Functional benefit
Products and services
- HeroTracker Inhaler Sensors Bluetooth-enabled medication inhaler tracker sensors compatible with most MDI and Diskus inhalers, designed to capture medication usage, timing, and frequency for patients with asthma and COPD. The sensors feed adherence data into Cohero Health's connected respiratory disease management platform for use by patients, clinicians, and care teams.
- MSpirometer Lung Function Sensor A Bluetooth-enabled connected spirometry device that measures peak flow, FEV1, FVC, and other key pulmonary metrics as a connected add-on for pressurized Metered Dose Inhalers, enabling remote lung function assessment for respiratory disease management.
- Respiratory Disease Management Platform An end-to-end mobile software platform that aggregates all respiratory data flows — adherence monitoring, lung function assessment, symptom reporting, and trigger identification — into a single smartphone app for asthma and COPD patients, with patient access to educational resources, training content, and direct communication channels with their care team and health coaches.
- Allergy Buddy Mobile App A proactive, user-centric companion mobile app for people living with allergic rhinitis and seasonal allergies that blends real-time local weather and air quality data with quick, easy check-ins to deliver clear guidance, supporting self-management between clinical visits.
Companies that use Cohero Health
Customer profileSegments1 record
Ideal customer profiles3 records
Cohero Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Cohero Health partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights4 records
Cohero Health competitors and assessment
Company assessmentEmerging players
- FindAir: European smart inhaler add-on sensor company focused on asthma and COPD medication adherence. Comparable product concept to Cohero but serving primarily European markets.
- HGE Health: Digital health company focused on remote patient monitoring for chronic conditions including COPD. Overlaps with Cohero in respiratory remote monitoring, though with a broader platform approach rather than inhaler sensors specifically.
- Wellinks: Digital health company offering connected respiratory devices (including spirometry) and remote monitoring for COPD and asthma patients. Comparable in scope of connected respiratory hardware + software for the same patient population.
Direct peers
- Aptar Digital Health: A division of Aptar Pharma offering 'HeroTracker' Bluetooth-enabled inhaler sensors and an end-to-end respiratory management platform with companion apps. Direct competitor to Cohero in connected inhaler technology, with a much broader portfolio including an MSpirometer lung function sensor.
- Propeller Health: Pioneer in connected inhaler sensors for asthma and COPD management; acquired by ResMed in 2019. Closely comparable product offering (smart inhaler sensors + adherence platform) and the most established player in Cohero's exact category.
- Adherium: Smart inhaler sensor company focused on medication adherence for asthma and COPD; offers the Hailie sensor compatible with multiple inhaler types. Directly comparable technology and target end-market to Cohero.
Broad incumbents
- Teva Pharmaceutical Industries: Launched the Digihaler line of FDA-cleared connected inhalers with built-in sensors for asthma/COPD. A vertically integrated pharma player that competes with Cohero by embedding smart-inhaler capability directly into branded drug-device combinations.
- ResMed: Global respiratory and sleep therapy leader; acquired Propeller Health to add connected inhaler capabilities to its sleep apnea and COPD portfolio. A scaled incumbent that competes with Cohero in respiratory digital health.
- AstraZeneca: Major respiratory pharma player (Symbicort, Breztri, Fasenra) that has invested in connected inhaler pilots and partnerships. Competes indirectly by integrating digital adherence features into its inhaled therapeutics franchises.
- GSK: Global pharma leader in respiratory (Trelegy, Nucala, Advair) actively exploring connected inhaler and adherence partnerships. A potential pharma partner or competitor to Cohero in the connected asthma/COPD space.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Cohero Health social profiles
Digital presenceCohero Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cohero Health leadership team
Management profileNumber of profiles
Profiles2 records
Cohero Health funding detail
Funding detailFunding overview
Funding rounds6 records
Investors15 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cohero Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cohero Health
What does Cohero Health do?
Cohero Health builds a connected respiratory health platform centered on proprietary Bluetooth-enabled smart inhaler sensors (HeroTracker) and a Bluetooth-enabled lung function sensor (MSpirometer) that capture medication usage, timing, frequency, and spirometry data for asthma and COPD patients. The hardware feeds a respiratory disease management software platform that aggregates adherence, lung function, symptom, and trigger data into a single mobile app for patients and their care teams. The platform also includes the Allergy Buddy companion app for allergic rhinitis and seasonal allergy self-management.
Is Cohero Health a public or private company?
Cohero Health is a private company. It is classified as corporate owned and is currently operating.
When was Cohero Health founded?
Cohero Health was founded in 2013. It employs 11 to 50 people.
Where is Cohero Health based?
Cohero Health is headquartered in New York, United States, in the North America region.
Who are Cohero Health's main competitors?
Emerging players on record are FindAir, HGE Health and Wellinks. Direct peers are Aptar Digital Health, Propeller Health and Adherium. Broad incumbents are Teva Pharmaceutical Industries, ResMed, AstraZeneca and GSK.
Does Cohero Health have an API?
No public API is recorded for Cohero Health.
What industry is Cohero Health in?
Cohero Health's product category is Digital Respiratory Health. Its primary akta.pro industry code is HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps), with a secondary code of HLAHAGAE, Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories). Its SIC code is 8090.